icobrain dm

icometrix

icobrain dm aims to assists healthcare professionals in achieving a diagnosis of dementia and Alzheimer’s disease (AD).

icobrain dm uncovers abnormality patterns by:
- Reporting sensitive brain volumetrics to allow the early detection of AD and other diseases causing dementia (whole brain and ventricular volumes and ratio).
- Quantifying and tracking cortical brain volumes and asymmetries to help with the differential diagnosis of the most common dementia types (frontal, parietal, temporal, occipital, and hippocampal cortex)
- Comparing volumes and volume changes to an age-and sex-matched normative reference population.
- Visualizing abnormality patterns in an intuitive volume signature.
Product specifications Information source: Vendor
Last updated: April 21, 2021
General
Product name icobrain dm
Company icometrix
Subspeciality Neuro
Modality MR, CT
Disease targeted dementia
Key-features brain region quantification, report generation, brain volume changes
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
Data characteristics
Population MCI, dementia, Alzheimer's, FTD, DLB, ...
Input For MRI: 3D T1 weighted image
Input format DICOM
Output Color-coded segmentation overlays, concise reports with reference statistics, pre-populated radiological reporting template
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform
Deployment Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time > 10 minutes
Certification
CE
Certified, Class I , MDD
FDA
510(k) cleared, Class II
Market presence
On market since 2018
Distribution channels Blackford, GE Edison marketplace, Nuance AI marketplace
Countries present (clinical, non-research use) 23
Paying clinical customers (institutes) >100
Research/test users (institutes) >300
Pricing
Pricing model Subscription
Based on Number of analyses
Evidence
Peer reviewed papers on performance

  • Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm (read)

Non-peer reviewed papers on performance
Other relevant papers